Related references
Note: Only part of the references are listed.Absence of disturbed axonal transport in spinal and bulbar muscular atrophy
Bilal Malik et al.
HUMAN MOLECULAR GENETICS (2011)
Impaired motoneuronal retrograde transport in two models of SBMA implicates two sites of androgen action
Michael Q. Kemp et al.
HUMAN MOLECULAR GENETICS (2011)
Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trial
Lindsay E. Fernandez-Rhodes et al.
LANCET NEUROLOGY (2011)
Dutasteride for spinal and bulbar muscular atrophy
Haruhiko Banno et al.
LANCET NEUROLOGY (2011)
Identifying polyglutamine protein species in situ that best predict neurodegeneration
Jason Miller et al.
NATURE CHEMICAL BIOLOGY (2011)
An Interdomain Interaction of the Androgen Receptor Is Required for Its Aggregation and Toxicity in Spinal and Bulbar Muscular Atrophy
Christopher R. Orr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial
Masahisa Katsuno et al.
LANCET NEUROLOGY (2010)
Native Functions of the Androgen Receptor Are Essential to Pathogenesis in a Drosophila Model of Spinobulbar Muscular Atrophy
Natalia B. Nedelsky et al.
NEURON (2010)
Phase 2 Trial of Leuprorelin in Patients with Spinal and Bulbar Muscular Atrophy
Haruhiko Banno et al.
ANNALS OF NEUROLOGY (2009)
Autophagy and access Understanding the role of androgen receptor subcellular localization in SBMA
Heather L. Montie et al.
AUTOPHAGY (2009)
17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse
Keisuke Tokui et al.
HUMAN MOLECULAR GENETICS (2009)
Mitochondrial abnormalities in spinal and bulbar muscular atrophy
Srikanth Ranganathan et al.
HUMAN MOLECULAR GENETICS (2009)
Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy
Heather L. Montie et al.
HUMAN MOLECULAR GENETICS (2009)
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data
Sarah J. Tabrizi et al.
LANCET NEUROLOGY (2009)
Effect of aerobic training in patients with spinal and bulbar muscular atrophy (Kennedy disease)
N. Preisler et al.
NEUROLOGY (2009)
Molecular genetics and biomarkers of polyglutamine diseases
Masahisa Katsuno et al.
CURRENT MOLECULAR MEDICINE (2008)
Huntington's disease: revisiting the aggregation hypothesis in polyglutamine neurodegenerative diseases
Ray Truant et al.
FEBS JOURNAL (2008)
Non-genomic actions of androgens
C. D. Foradori et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2008)
Polyglutarnine neurodegeneration: protein misfolding revisited
Aislinn J. Williams et al.
TRENDS IN NEUROSCIENCES (2008)
Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic
Toshiaki Takahashi et al.
HUMAN MOLECULAR GENETICS (2008)
CAG repeat size correlates to electrophysiological motor and sensory phenotypes in SBMA
Keisuke Suzuki et al.
BRAIN (2008)
Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease
Douglas Ashley Monks et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A toxic monomeric conformer of the polyglutamine protein
Yoshitaka Nagai et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)
ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor
Zhiming Yang et al.
NATURE MEDICINE (2007)
Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration
Masahisa Katsuno et al.
JOURNAL OF NEUROSCIENCE (2006)
JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport
Gerardo Morfini et al.
NATURE NEUROSCIENCE (2006)
Pathogenesis, animal models and therapeutics in Spinal and bulbar muscular atrophy (SBMA)
Masahisa Katsuno et al.
EXPERIMENTAL NEUROLOGY (2006)
Preparing for preventive clinical trials - The predict-HD study
JS Paulsen et al.
ARCHIVES OF NEUROLOGY (2006)
Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients
Naoki Atsuta et al.
BRAIN (2006)
Pharmacologic and genetic inhibition of hsp90-dependent trafficking reduces aggregation and promotes degradation of the expanded glutamine androgen receptor without stress protein induction
Monzy Thomas et al.
HUMAN MOLECULAR GENETICS (2006)
Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: A pathogenic marker
H Banno et al.
ANNALS OF NEUROLOGY (2006)
Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease
M Katsuno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration
M Waza et al.
NATURE MEDICINE (2005)
Diseases of unstable repeat expansion: Mechanisms and common principles
JR Gatchel et al.
NATURE REVIEWS GENETICS (2005)
Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease
F Borovecki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Widespread nuclear and cytoplasmic accumulation of mutant androgen receptor in SBMA patients
H Adachi et al.
BRAIN (2005)
The polyglutamine tract of androgen receptor: from functions to dysfunctions in motor neurons
A Poletti
FRONTIERS IN NEUROENDOCRINOLOGY (2004)
Neurologic course, endocrine dysfunction and triplet repeat size in spinal bulbar muscular atrophy
M Sinnreich et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2004)
Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy
M Minamiyama et al.
HUMAN MOLECULAR GENETICS (2004)
Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
M Arrasate et al.
NATURE (2004)
Castration restores function and neurofilament alterations of aged symptomatic males in a transgenic mouse model of spinal and bulbar muscular atrophy
ES Chevalier-Larsen et al.
JOURNAL OF NEUROSCIENCE (2004)
Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy
M Katsuno et al.
NATURE MEDICINE (2003)
Huntingtin aggregation and toxicity in Huntington's disease
G Bates
LANCET (2003)
Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein
JP Taylor et al.
HUMAN MOLECULAR GENETICS (2003)
Oligodendrocytic polyglutamine pathology in dentatorubral-pallidoluysian atrophy
M Yamada et al.
ANNALS OF NEUROLOGY (2002)
Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy
M Katsuno et al.
NEURON (2002)
Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila
K Takeyama et al.
NEURON (2002)
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
JS Steffan et al.
NATURE (2001)
Epidemiological survey of X-linked bulbar and spinal muscular atrophy, or Kennedy disease, in the province of Reggio Emilia, Italy
D Guidetti et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2001)
CREB-binding protein sequestration by expanded polyglutamine
A McCampbell et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
